290 related articles for article (PubMed ID: 1462605)
21. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
[TBL] [Abstract][Full Text] [Related]
22. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twenty-fourth report.
World Health Organ Tech Rep Ser; 1972; 487():1-86. PubMed ID: 4623961
[No Abstract] [Full Text] [Related]
23. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 1980; 645():1-54. PubMed ID: 6774485
[No Abstract] [Full Text] [Related]
24. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2011; (961):1-428, back cover. PubMed ID: 21699061
[TBL] [Abstract][Full Text] [Related]
25. Ingredients in pharmaceutical preparations: a problem not value.
Lubner GC
Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372
[No Abstract] [Full Text] [Related]
26. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
World Health Organization
World Health Organ Tech Rep Ser; 2015; (992):1-210, back cover. PubMed ID: 26118121
[TBL] [Abstract][Full Text] [Related]
27. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
WHO Expert Committee on Specifications for Pharmaceutical Preparations
World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
[TBL] [Abstract][Full Text] [Related]
28. Inspections: the international regulatory view--Japan.
Kamura S
PDA J Pharm Sci Technol; 1994; 48(4):182-3. PubMed ID: 7804816
[No Abstract] [Full Text] [Related]
29. Pharmaceutical reference standards.
Wallén O
WHO Chron; 1972 Sep; 26(9):389-92. PubMed ID: 5076978
[No Abstract] [Full Text] [Related]
30. [Standards imposed by the pharmacopoeia on drugs].
Büchi J
Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534
[No Abstract] [Full Text] [Related]
31. [Quality control in the pharmaceutical industry].
Bretscher E
Pharm Acta Helv; 1972; 47(11):664-75. PubMed ID: 4657535
[No Abstract] [Full Text] [Related]
32. Intended use of reference products & WHO International Standards/Reference Reagents in the development of similar biological products (biosimilars).
Thorpe R; Wadhwa M
Biologicals; 2011 Sep; 39(5):262-5. PubMed ID: 21880508
[TBL] [Abstract][Full Text] [Related]
33. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
Wagler M
Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
[No Abstract] [Full Text] [Related]
34. Specifications from a biotechnology industry perspective.
Garnick RL
Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
[TBL] [Abstract][Full Text] [Related]
35. Specifications for the quality control of pharmaceutical preparations.
WHO Chron; 1967 Oct; 21(10):438-40. PubMed ID: 6060394
[No Abstract] [Full Text] [Related]
36. WHO expert committee on specifications for pharmaceutical preparations.
World Health Organ Tech Rep Ser; 2002; 902():i-vii, 1-208. PubMed ID: 12082969
[TBL] [Abstract][Full Text] [Related]
37. [Role of the Pharmacopoeia Committee of the Ministry of Public Health of the USSR in improving drug preparation quality].
Oboĭmakova OM
Farm Zh; 1977; 32(4):28-31. PubMed ID: 913542
[No Abstract] [Full Text] [Related]
38. Pharmacopoeia as quality codex for the manufacturers.
Soldi A
Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728
[TBL] [Abstract][Full Text] [Related]
39. Report on the PQRI impurity characterization and quantification best practices survey.
Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
[No Abstract] [Full Text] [Related]
40. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
